Loading
Alembic Pharmaceuticals Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Nirayu Private Limited, was filed 19 Jun 2026.
Insider Decl.
40
Thresholds
n/a
Buy Volume
€6M
32 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleChirayu Ramanbhai Amin HUF15 buys
Nirayu Private Limited8 buys
Nirayu Limited2 buys
-1 buy
Since the insiders bought
- +0.9%Entry ₹780.85 · Close 21 Oct 2026 ₹787.95
- -12.9%Entry ₹904.30 · Close 21 Oct 2026 ₹787.95
- -13.4%Entry ₹909.90 · Close 21 Oct 2026 ₹787.95
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Alembic Pharmaceuticals Limited Buy (bullish), based on 10 analysts. Average price target: ₹961.80.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 8,928 of 26,284 companies
59.5
score / 100
Value48
Quality72
FCF yld1.9%
Earn yld4.3%
EV/EBITDA15.3x
ROE12%
Gross mgn67%
Net mgn9.4%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹790.35
Analyst consensus
10 analystsBuy
₹835.00Target ₹961.80(+22%)₹1,132.00
Income statement
Revenue₹72.1B
Gross profit₹48.5B67% margin
EBITDA₹11.1B15% margin
Net income₹6.7B8.9% margin
Valuation
PER (trailing)22.4x
PER (forward)16.1x
P/Book2.7x
Beta0.32
Balance sheet & cash
Market cap₹155.4B
Total debt₹14.3B
Free Cash Flow₹2.9B
Debt / Equity25%
Profitability & ownership
ROE12.4%
ROA6.0%
% insiders70.7%
% institutions16.8%
Last declaration on 19 June 2026
Declarations40 total
3,278 shares@ ₹743.500.0016% mcap1.3% of flowEquity SharesMarket PurchaseSEBI:0f3fd4e19000e9b92f6fb742239b0fb347ecc9d0
Canonical exit: 17 Sept 2026 (T+90)
24,832 shares@ ₹746.300.012% mcap9.6% of flowEquity SharesMarket PurchaseSEBI:635e56dbe8ddfea409988c2ae2c9b8aeb07545a1
Canonical exit: 16 Sept 2026 (T+90)
75,000 shares@ ₹746.000.035% mcap28.6% of flowEquity SharesMarket PurchaseSEBI:fd53d3099905b66fd87728a8dd10c66ff04543cf
Canonical exit: 10 Sept 2026 (T+90)
20,000 shares@ ₹744.007.5% of flowEquity SharesMarket PurchaseSEBI:9515f001518915fd32ca4609945968133d986788
Canonical exit: 1 Sept 2026 (T+90)
78,000 shares@ ₹762.5030.0% of flowEquity SharesMarket PurchaseSEBI:010ada55f01065d17b85981c1127f024a82dd423
Canonical exit: 26 Aug 2026 (T+90)
60,000 shares@ ₹758.0023.1% of flowEquity SharesMarket PurchaseSEBI:3660fa3496803de67527703cc3e8ff54a498d345
Canonical exit: 23 Aug 2026 (T+90)
10,000 shares@ ₹903.548366.6% of flowEquity SharesSEBI:1b94b52d1d415f697ac10bdce2ccfae700520c99
Canonical exit: 28 Dec 2025 (T+90)
5,000 shares@ ₹901.784233.4% of flowEquity SharesSEBI:b5211dcc2e861009fca8cb88a607400b23fc641c
Canonical exit: 25 Dec 2025 (T+90)
15,000 shares@ ₹925.36797.7% of flowEquity SharesSEBI:cd2150545913dd76eacc254f780d941e3019b11e
Canonical exit: 24 Dec 2025 (T+90)
5,200 shares@ ₹962.23382.8% of flowEquity SharesSEBI:662dae5335f9ca83fa3c63c970f609cd62e01bb0
Canonical exit: 14 Dec 2025 (T+90)
25,000 shares@ ₹959.338213.4% of flowEquity SharesSEBI:35a439217dcd4247db460458ac44c3da3063f04e
Canonical exit: 9 Dec 2025 (T+90)
20,000 shares@ ₹948.048910.5% of flowEquity SharesSEBI:9818b3545b8d2e95db2b90959c04dae771579b98
Canonical exit: 7 Dec 2025 (T+90)
13,068 shares@ ₹963.48857.1% of flowEquity SharesSEBI:3095b7afca7bbb0cd28b384f1eda4805f26b7888
Canonical exit: 3 Dec 2025 (T+90)
20,000 shares@ ₹955.979610.7% of flowEquity SharesSEBI:a2fb2cd918025c65fa550235b475adb97f292e2b
Canonical exit: 2 Dec 2025 (T+90)
13,290 shares@ ₹941.24677.0% of flowEquity SharesSEBI:26d1226e2035a74c185ed4c1373c5d415feec634
Canonical exit: 30 Nov 2025 (T+90)
12,665 shares@ ₹905.13363.9% of flowEquity SharesSEBI:b40990a01b341930b3b4051874d2b4791839ffd0
Canonical exit: 25 Jun 2025 (T+90)
7,600 shares@ ₹866.741636.1% of flowEquity SharesSEBI:424184a624fbce88c70c61906cc7a466320ae8cd
Canonical exit: 19 Jun 2025 (T+90)
2,000 shares@ ₹834.4581.0% of flowEquity SharesSEBI:58b78125a1b8695caddbfed26094c2df456ade0e
Canonical exit: 18 Jun 2025 (T+90)
1,500 shares@ ₹832.5220.8% of flowEquity SharesSEBI:b25e1c898360005ff18482eed24c2429eced51a1
Canonical exit: 16 Jun 2025 (T+90)
5,832 shares@ ₹826.24732.9% of flowEquity SharesSEBI:cc119bbb3e3894d7d9dad5cf31fe6adc790e4c32
Canonical exit: 11 Jun 2025 (T+90)
50,000 shares@ ₹778.250524.5% of flowEquity SharesSEBI:6f82e3664d8d038c24bd4209f02666b102e919b9
Canonical exit: 28 May 2025 (T+90)
7,426 shares@ ₹797.91143.7% of flowEquity SharesSEBI:a2513d3330ecdc3a0737d0832f417e207e025dd8
Canonical exit: 25 May 2025 (T+90)
4,247 shares@ ₹806.14222.2% of flowEquity SharesSEBI:ff4b01cb024a863b5b6d42a9199b54b0abbd3f81
Canonical exit: 22 May 2025 (T+90)
959 shares@ ₹811.91870.5% of flowEquity SharesSEBI:d0e3a8f0f9d56205846b6d9d34897bfda309ccfd
Canonical exit: 21 May 2025 (T+90)
10,000 shares@ ₹812.9015.2% of flowEquity SharesSEBI:ee9f9744565e906c2ac0e1aa559c45e25b7ed66b
Canonical exit: 15 May 2025 (T+90)
25 of 40 declarations
About Alembic Pharmaceuticals Limited
There is no sale at all at Alembic Pharmaceuticals Limited, an Indian healthcare company listed on the Bombay Stock Exchange: 32 purchases, every one with an amount, worth EUR 6.3 million with a median of EUR 123,438. The two largest, EUR 1.2 million on February 25, 2022 and EUR 588,569 on March 2, 2022, are filed under Alembic Limited; the third, EUR 533,045 on May 28, 2026, under Nirayu Private Limited (Promoter Group).
A buying cluster shows from September 1 to September 29, 2025, when 2 filers bought for EUR 1.2 million. Across the full history, 12 purchase filings are classed as clustered. Chirayu Ramanbhai Amin HUF made 17 filings, 15 of them purchases, Nirayu Private Limited made 6 purchases (Promoter Group) and 2 more filings, Alembic Limited made 4 purchases and Nirayu Limited 2.
Read moreShow less
The 40 filings were published from September 23, 2021 to June 19, 2026: 1 in 2021, 11 in 2022, 2 in 2023, 20 in 2025 and 6 in 2026. The 14 filers hold 70.7% of the capital, valued at INR 155.4 billion. Stored 90-day results cover 32 purchases: median 2.5%, 63% positive. They are past results on record, not a forecast. Median publication delay: 1 day.
